304 related articles for article (PubMed ID: 29523896)
1. A Review of the Current Evidence on Gadolinium Deposition in the Brain.
Pullicino R; Radon M; Biswas S; Bhojak M; Das K
Clin Neuroradiol; 2018 Jun; 28(2):159-169. PubMed ID: 29523896
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.
Stojanov D; Aracki-Trenkic A; Benedeto-Stojanov D
Neuroradiology; 2016 May; 58(5):433-41. PubMed ID: 26873830
[TBL] [Abstract][Full Text] [Related]
3. Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast.
Roberts DR; Holden KR
Brain Dev; 2016 Mar; 38(3):331-6. PubMed ID: 26345358
[TBL] [Abstract][Full Text] [Related]
4. High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification.
Barbieri S; Schroeder C; Froehlich JM; Pasch A; Thoeny HC
Contrast Media Mol Imaging; 2016 May; 11(3):245-50. PubMed ID: 26929131
[TBL] [Abstract][Full Text] [Related]
5. Does renal function affect gadolinium deposition in the brain?
Rahatli FK; Donmez FY; Kibaroglu S; Kesim C; Haberal KM; Turnaoglu H; Agildere AM
Eur J Radiol; 2018 Jul; 104():33-37. PubMed ID: 29857863
[TBL] [Abstract][Full Text] [Related]
6. Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.
Forslin Y; Shams S; Hashim F; Aspelin P; Bergendal G; Martola J; Fredrikson S; Kristoffersen-Wiberg M; Granberg T
AJNR Am J Neuroradiol; 2017 Jul; 38(7):1311-1316. PubMed ID: 28495943
[TBL] [Abstract][Full Text] [Related]
7. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
Kasper E; Schemuth HP; Horry S; Kinner S
Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium deposition in the brain: summary of evidence and recommendations.
Gulani V; Calamante F; Shellock FG; Kanal E; Reeder SB;
Lancet Neurol; 2017 Jul; 16(7):564-570. PubMed ID: 28653648
[TBL] [Abstract][Full Text] [Related]
9. Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams.
Hu HH; Pokorney A; Towbin RB; Miller JH
Pediatr Radiol; 2016 Oct; 46(11):1590-8. PubMed ID: 27282825
[TBL] [Abstract][Full Text] [Related]
10. Distribution and chemical forms of gadolinium in the brain: a review.
Kanda T; Nakai Y; Hagiwara A; Oba H; Toyoda K; Furui S
Br J Radiol; 2017 Nov; 90(1079):20170115. PubMed ID: 28749164
[TBL] [Abstract][Full Text] [Related]
11. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.
Kanda T; Ishii K; Kawaguchi H; Kitajima K; Takenaka D
Radiology; 2014 Mar; 270(3):834-41. PubMed ID: 24475844
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium Deposition in Humans: When Did We Learn That Gadolinium Was Deposited In Vivo?
Huckle JE; Altun E; Jay M; Semelka RC
Invest Radiol; 2016 Apr; 51(4):236-40. PubMed ID: 26588463
[TBL] [Abstract][Full Text] [Related]
13. Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function.
Murata N; Gonzalez-Cuyar LF; Murata K; Fligner C; Dills R; Hippe D; Maravilla KR
Invest Radiol; 2016 Jul; 51(7):447-53. PubMed ID: 26863577
[TBL] [Abstract][Full Text] [Related]
14. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
15. Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children.
Rossi Espagnet MC; Bernardi B; Pasquini L; Figà-Talamanca L; Tomà P; Napolitano A
Pediatr Radiol; 2017 Sep; 47(10):1345-1352. PubMed ID: 28526896
[TBL] [Abstract][Full Text] [Related]
16. Gray Matter Nucleus Hyperintensity After Monthly Triple-Dose Gadopentetate Dimeglumine With Long-term Magnetic Resonance Imaging.
DeBevits JJ; Munbodh R; Bageac D; Wu R; DiCamillo PA; Hu C; Wang L; Naismith RT; Karimeddini D; Dhib-Jalbut S; Redko S; Cook SD; Cadavid D; Wolansky L
Invest Radiol; 2020 Oct; 55(10):629-635. PubMed ID: 32898355
[TBL] [Abstract][Full Text] [Related]
17. Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients.
Lee JY; Park JE; Kim HS; Kim SO; Oh JY; Shim WH; Jung SC; Choi CG; Kim SJ
PLoS One; 2017; 12(8):e0183916. PubMed ID: 28859167
[TBL] [Abstract][Full Text] [Related]
18. Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents.
Chehabeddine L; Al Saleh T; Baalbaki M; Saleh E; Khoury SJ; Hannoun S
Crit Rev Toxicol; 2019 Mar; 49(3):262-279. PubMed ID: 30942117
[TBL] [Abstract][Full Text] [Related]
19. High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol.
Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Invest Radiol; 2015 Dec; 50(12):805-10. PubMed ID: 26523910
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium presence, MRI hyperintensities, and glucose uptake in the hypoperfused rat brain after repeated administrations of gadodiamide.
Arena F; Bardini P; Blasi F; Gianolio E; Marini GM; La Cava F; Valbusa G; Aime S
Neuroradiology; 2019 Feb; 61(2):163-173. PubMed ID: 30377745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
